These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26 related articles for article (PubMed ID: 8212075)
1. Synthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma. Takeda Y; Lewicka S; Koch S; Bige K; Vecsei P; Abdelhamid S; Cojocaru M; Harnik M J Steroid Biochem Mol Biol; 1990 Nov; 37(4):599-604. PubMed ID: 2278845 [TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of 19-noraldosterone, 18, 19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone in patients with aldosterone-producing adenoma or idiopathic hyperaldosteronism. Takeda Y; Miyamori I; Iki K; Takeda R; Vecsei P Acta Endocrinol (Copenh); 1992 Jun; 126(6):484-8. PubMed ID: 1642080 [TBL] [Abstract][Full Text] [Related]
3. Proceedings: Steroid production rates in two patients with corticosterone-producing adenomata. Edwards OM; Galley JM; Tait AD; Mills IH J Endocrinol; 1975 Jun; 65(3):52P-53P. PubMed ID: 1151252 [No Abstract] [Full Text] [Related]
4. Zona fasciculata origin of 18-hydroxycorticosterone in the chronically suppressed zona glomerulosa. Kater CE; Biglieri EG J Clin Endocrinol Metab; 1982 Oct; 55(4):628-33. PubMed ID: 7107809 [No Abstract] [Full Text] [Related]
5. Formation of 18-deoxy-19-noraldosterone by a human aldosterone-producing adenoma. Takeda Y; Iki K; Miyamori I; Takeda R Steroids; 1993 Jun; 58(6):282-5. PubMed ID: 8212075 [TBL] [Abstract][Full Text] [Related]
6. Significance of 19-noraldosterone, a new mineralocorticoid, in clinical and experimental hypertension. Takeda Y; Miyamori I; Takeda R Steroids; 1995 Jan; 60(1):137-42. PubMed ID: 7792799 [TBL] [Abstract][Full Text] [Related]